Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
Thomas HD, Calabrese CR, Batey MA, Canan S, Hostomsky Z, Kyle S, Maegley KA, Newell DR, Skalitzky D, Wang LZ, Webber SE, Curtin NJ.
Thomas HD, et al.
Mol Cancer Ther. 2007 Mar;6(3):945-56. doi: 10.1158/1535-7163.MCT-06-0552.
Mol Cancer Ther. 2007.
PMID: 17363489